Original-Research: Singulus (von NuWays AG): Halten
Original-Research: Singulus - from NuWays AG
Classification of NuWays AG to Singulus
Company Name: Singulus
ISIN: DE000A1681X5
Reason for the research: Update
Recommendation: Halten
Target price: EUR 1.60
Target price on sight of: 12 Monaten
Last rating change:
Analyst: Konstantin Völk
Good start into 2024 and strong order intake; chg. est.
Topic: Singulus reported solid Q1 figures with sales and EBIT above our estimates. Order intake came in strong as already announced on the FY23 CC in April.
Q1 sales increased 26% yoy to € 20.6m (eNuW: € 18.6m), despite a low order backlog of € 55m end of FY23. Q1 EBIT stood at € 0.6m (eNuW: € -1.3m), up from last year’s Q1 (€ -0.9m). Growth was particularly driven by the Solar (+24%) and Life Science (+50%) segments. Life Science recovered from a low level in FY23 which was affected by a challenging macro environment and is gaining traction again. For instance, the MEDLINE production system from Singulus for the processing of contact lenses is steadily gaining acceptance in the market (company news May 14). In FY24e, Solar should again be the most important segment (eNuW: € 50m; + 28% yoy) thanks to CdTe follow-up orders from CNBM as well as potential orders from Enel as they start their new project in the US.
Order intake improved significantly to € 33.2m, a 136% increase yoy due to the strong demand in the semiconductor segment. Furthermore, management expects the order intake to stay at a similar high level for the second quarter.
Successful refinancing: The € 10m loan from Bank of Shanghai which expired on May 9, 2024 was successfully refinanced at the end of April with comparable conditions and a term of 12 months. In addition, Singulus is discussing another € 10m loan from Bank of Shanghai to finance the currently increasing working capital and repayment of debt tranches maturing in FY24e.
Guidance confirmed: Management confirmed its guidance of € 120-130m sales and EBIT in the low double-digit million range. However, despite the strong order intake of € 33.2m in Q1, the outlook appears ambitious given the difficult macro environment and the challenging situation of the solar industry in Europe due to low-cost solar modules from China. That said, Singulus is on a good way to reach operating breakeven this year (eNuW: sales € 97m; EBIT € 0.2m) after five years of negative EBIT (adjusted for the extraordinary income of € 12.1m in FY22 from a property sale).
Singulus midterm prospects remain intact with the potential of larger orders from CNBM for CdTe thinfilm modules and a fast-growing μLED and hydrogen business. Yet, as this is already reflected in the current valuation, in our view, we reiterate HOLD with an unchanged PT of € 1.60 based on DCF.
You can download the research here:
http://www.more-ir.de/d/29771.pdf
For additional information visit our website
www.nuways-ag.com/research.
Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
-------------------transmitted by EQS Group AG.-------------------
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 127,50 | 79,00 | 29,50 | 68,70 | 87,80 | 72,50 | 86,00 | |
| EBITDA1,2 | 9,10 | -3,30 | -25,90 | -8,60 | 9,50 | -7,30 | 5,80 | |
| EBITDA-Margin3 | 7,14 | -4,18 | -87,80 | -12,52 | 10,82 | -10,07 | 6,74 | |
| EBIT1,4 | 6,80 | -7,50 | -36,80 | -12,40 | 5,90 | -10,10 | 2,40 | |
| EBIT-Margin5 | 5,33 | -9,49 | -124,75 | -18,05 | 6,72 | -13,93 | 2,79 | |
| Net Profit (Loss)1 | 0,80 | -10,70 | -36,20 | -14,20 | -0,10 | -9,80 | -0,20 | |
| Net-Margin6 | 0,63 | -13,54 | -122,71 | -20,67 | -0,11 | -13,52 | -0,23 | |
| Cashflow1,7 | 2,50 | -3,20 | 2,70 | 24,10 | -22,60 | -26,30 | 0,00 | |
| Earnings per share8 | 0,09 | -1,20 | -4,07 | -1,60 | -0,01 | -1,10 | -0,02 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Baker Tilly
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Singulus Technologies | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A1681X | DE000A1681X5 | AG | 10,28 Mio € | 25.11.1997 | 9F2F32J2+GP | |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 16,50 | 2,04 | 8,10 | -1,02 | -0,23 | -0,39 | 0,14 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 21.05.2025 | 13.05.2025 | 13.08.2025 | 13.11.2024 | 28.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -13,81% | -18,72% | -29,79% | -28,92% | -99,99% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
